🇺🇸 NSE dosage "hypothermia arm" in United States

30,310 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 30,310

Most-reported reactions

1. Hypothermia — 9,751 reports (32.17%)
2. Hypotension — 3,090 reports (10.19%)
3. Off Label Use — 2,423 reports (7.99%)
4. Nausea — 2,378 reports (7.85%)
5. Acute Kidney Injury — 2,318 reports (7.65%)
6. Drug Ineffective — 2,272 reports (7.5%)
7. Diarrhoea — 2,213 reports (7.3%)
8. Vomiting — 2,001 reports (6.6%)
9. Complication Associated With Device — 1,988 reports (6.56%)
10. Fatigue — 1,876 reports (6.19%)

Source database →

Frequently asked questions

Is NSE dosage "hypothermia arm" approved in United States?

NSE dosage "hypothermia arm" does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for NSE dosage "hypothermia arm" in United States?

Centre Hospitalier Departemental Vendee is the originator. The local marketing authorisation holder may differ — check the official source linked above.